FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2026501379> ?p ?o ?g. }

• W2026501379 endingPage "358" @default.
• W2026501379 startingPage "352" @default.
• W2026501379 abstract "To investigate the anti-inflammatory effect of erythropoietin (EPO) pretreatment on cardiomyocytes exposed to hypoxia/reoxygenation injury (H/R) and explore the possible mechanism. The cultured neonatal rats’ ventricular cardiomyocytes were divided randomly into 4 groups, control group (C group), EPO pretreatment group (E group), EPO and pyrrolidine dithiocarbamate (PDTC) pretreatment group (EP group) and PDTC pretreatment group (P group). After 24 hours’ pretreatment, the cardiomyocytes were exposed to H/R. After pretreatment and H/R, the expression of tumor necrosis factor-α(TNF-α) gene in all the groups was detected by RT-PCR and Western blot. The nuclear factor-κB (NF-κB) activity was detected by electrophoretic mobility shift assay (EMSA) and the inhibitor-κBα (I-κBα) protein level was detected by Western blot. The decrement of I-κBαprotein and the increasing NF-κB activity were found in cardiomyocytes pretreated with EPO beforeH/Rcompared to other groups (t=3.321, 4.183, P<0.01). However, after H/R, NF-κB activity and expression of TNF-α gene were significantly reduced, I-κBα protein expression was increased in cardiomyocytes of E group compared to other groups (t=3.425, 3.687, 3.454, P<0.01). All theses changes caused by EPO pretreatment were eliminated by the intervention of PDTC (an antagonist to NF-κB) during pretreatment. EPO pretreatment can inhibit the activation of NF-κB and upregulation of TNF-α gene in cardiomyocytes exposed to H/R through a negative feedback of NF-κB signaling pathway, and thus produces the anti-inflammatory effect. This might be one of the ways EPO produces the anti-inflammatory effect." @default.
• W2026501379 created "2016-06-24" @default.
• W2026501379 creator A5058216867 @default.
• W2026501379 creator A5068898389 @default.
• W2026501379 creator A5078143614 @default.
• W2026501379 creator A5084138890 @default.
• W2026501379 creator A5089279097 @default.
• W2026501379 date "2008-12-01" @default.
• W2026501379 modified "2023-09-27" @default.
• W2026501379 title "Anti-inflammatory effect of erythropoietin pretreatment on cardiomyocytes with hypoxia/reoxygenation injury and the possible mechanism" @default.
• W2026501379 cites W1931137354 @default.
• W2026501379 cites W1984257914 @default.
• W2026501379 cites W1991352341 @default.
• W2026501379 cites W2016730049 @default.
• W2026501379 cites W2021236226 @default.
• W2026501379 cites W2043188295 @default.
• W2026501379 cites W2045677954 @default.
• W2026501379 cites W2055349500 @default.
• W2026501379 cites W2058141781 @default.
• W2026501379 cites W2064048040 @default.
• W2026501379 cites W2066323398 @default.
• W2026501379 cites W2072223552 @default.
• W2026501379 cites W2077912859 @default.
• W2026501379 cites W2079387700 @default.
• W2026501379 cites W2083309686 @default.
• W2026501379 cites W2087357068 @default.
• W2026501379 cites W2108089603 @default.
• W2026501379 cites W2108712459 @default.
• W2026501379 cites W2137002490 @default.
• W2026501379 cites W2142463112 @default.
• W2026501379 cites W2142984634 @default.
• W2026501379 cites W2157113161 @default.
• W2026501379 cites W2165673197 @default.
• W2026501379 cites W2465298555 @default.
• W2026501379 doi "https://doi.org/10.1016/s1008-1275(08)60071-1" @default.
• W2026501379 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/19032850" @default.
• W2026501379 hasPublicationYear "2008" @default.
• W2026501379 type Work @default.
• W2026501379 sameAs 2026501379 @default.
• W2026501379 citedByCount "4" @default.
• W2026501379 countsByYear W20265013792012 @default.
• W2026501379 countsByYear W20265013792014 @default.
• W2026501379 countsByYear W20265013792017 @default.
• W2026501379 crossrefType "journal-article" @default.
• W2026501379 hasAuthorship W2026501379A5058216867 @default.
• W2026501379 hasAuthorship W2026501379A5068898389 @default.
• W2026501379 hasAuthorship W2026501379A5078143614 @default.
• W2026501379 hasAuthorship W2026501379A5084138890 @default.
• W2026501379 hasAuthorship W2026501379A5089279097 @default.
• W2026501379 hasBestOaLocation W20265013791 @default.
• W2026501379 hasConcept C104317684 @default.
• W2026501379 hasConcept C123298856 @default.
• W2026501379 hasConcept C126322002 @default.
• W2026501379 hasConcept C127561419 @default.
• W2026501379 hasConcept C134018914 @default.
• W2026501379 hasConcept C150194340 @default.
• W2026501379 hasConcept C178790620 @default.
• W2026501379 hasConcept C17991360 @default.
• W2026501379 hasConcept C183978625 @default.
• W2026501379 hasConcept C185592680 @default.
• W2026501379 hasConcept C2776415932 @default.
• W2026501379 hasConcept C2777730290 @default.
• W2026501379 hasConcept C2778534260 @default.
• W2026501379 hasConcept C2779730028 @default.
• W2026501379 hasConcept C2780983412 @default.
• W2026501379 hasConcept C540031477 @default.
• W2026501379 hasConcept C55493867 @default.
• W2026501379 hasConcept C62478195 @default.
• W2026501379 hasConcept C71924100 @default.
• W2026501379 hasConcept C7836513 @default.
• W2026501379 hasConcept C86339819 @default.
• W2026501379 hasConcept C98274493 @default.
• W2026501379 hasConceptScore W2026501379C104317684 @default.
• W2026501379 hasConceptScore W2026501379C123298856 @default.
• W2026501379 hasConceptScore W2026501379C126322002 @default.
• W2026501379 hasConceptScore W2026501379C127561419 @default.
• W2026501379 hasConceptScore W2026501379C134018914 @default.
• W2026501379 hasConceptScore W2026501379C150194340 @default.
• W2026501379 hasConceptScore W2026501379C178790620 @default.
• W2026501379 hasConceptScore W2026501379C17991360 @default.
• W2026501379 hasConceptScore W2026501379C183978625 @default.
• W2026501379 hasConceptScore W2026501379C185592680 @default.
• W2026501379 hasConceptScore W2026501379C2776415932 @default.
• W2026501379 hasConceptScore W2026501379C2777730290 @default.
• W2026501379 hasConceptScore W2026501379C2778534260 @default.
• W2026501379 hasConceptScore W2026501379C2779730028 @default.
• W2026501379 hasConceptScore W2026501379C2780983412 @default.
• W2026501379 hasConceptScore W2026501379C540031477 @default.
• W2026501379 hasConceptScore W2026501379C55493867 @default.
• W2026501379 hasConceptScore W2026501379C62478195 @default.
• W2026501379 hasConceptScore W2026501379C71924100 @default.
• W2026501379 hasConceptScore W2026501379C7836513 @default.
• W2026501379 hasConceptScore W2026501379C86339819 @default.
• W2026501379 hasConceptScore W2026501379C98274493 @default.
• W2026501379 hasIssue "6" @default.
• W2026501379 hasLocation W20265013791 @default.
• W2026501379 hasLocation W20265013792 @default.
• W2026501379 hasOpenAccess W2026501379 @default.

• next